Published in Health Business Week, September 30th, 2005
Proceeds from the financing will be used to conduct clinical testing of the company's GP88 Biopsy Staining Kit for breast cancer, under development to help physicians determine prognosis and aid in determining the risk of breast cancer recurrence.
New England Partners served as lead investor for the financing. Other participating investors include the Maryland Venture Fund (the venture arm of the Maryland Department of Business and Economic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.